COMMUNIQUÉS West-GlobeNewswire

Strongbridge Biopharma plc Reports Third Quarter 2018 Financial Results and Provides Corporate Update
31/10/2018
~ Financial Position to be Significantly Strengthened in Fourth Quarter 2018 by $145 Million of Upfront Cash and $36.7 Million Equity Investment from Separately Announced Transactions with Novo Nordisk; Company Intends [...]
Golden Leaf Holdings to Hold Conference Call to Review Third Quarter 2018 Results
31/10/2018
PORTLAND, Ore., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
Strongbridge Biopharma plc Enters into Agreement for Novo Nordisk to Acquire the U.S. and Canadian Rights to MACRILEN™ (macimorelin)
31/10/2018
~ Strongbridge to Receive Upfront Payment of $145 Million and Tiered Royalty Stream from Novo Nordisk ~ ~ Novo Nordisk to Purchase Approximately 5.2 Million Ordinary Shares of Strongbridge Biopharma plc at Purchase [...]
Marrone Bio Innovations to Report Third Quarter 2018 Financial Results on Tuesday, November 13th at 4:30 p.m. Eastern Time
31/10/2018
DAVIS, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, will release financial results for [...]
Laura Clague Named to Fluidigm Board of Directors
31/10/2018
Senior Financial Leader with Broad Corporate and Biotech Expertise SOUTH SAN FRANCISCO, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Laura M. Clague to [...]
Arbutus to Report Third Quarter 2018 Financial Results
31/10/2018
WARMINSTER, Pa., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its third [...]
Tower One October Update
31/10/2018
VANCOUVER, British Columbia, Oct. 31, 2018 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces it has begun the construction of 16 towers in [...]
Director/PDMR Shareholding
31/10/2018
DXS INTERNATIONAL PLC Director Dealing The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that [...]
Catalyst Pharmaceuticals to Hold Third Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, November 8th, 2018
31/10/2018
CORAL GABLES, Fla., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Nexstim Plc: Invitation to the Extraordinary General Meeting
31/10/2018
Company announcement, Helsinki, 31 October 2018 at 2:00 PM Nexstim Plc: Invitation to the Extraordinary General Meeting Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing [...]
Nuvectra® to Participate in Two Upcoming Investor Conferences
31/10/2018
PLANO, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief [...]
Study: Liberals and news junkies on edge as midterms approach
31/10/2018
Left-leaning politics, frequent news consumption tied to greater anxiety symptoms SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- With the midterm elections less than a week away, anxiety in America is running high. [...]
CASMED Reports Third-Quarter 2018 Financial Results
31/10/2018
FORE-SIGHT® sales increase 20%; sensor sales up 22% on 20% growth in the U.S.; operating loss narrows by 25% Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) -- CAS [...]
Chembio to Report Third Quarter 2018 Financial Results on November 8, 2018
31/10/2018
MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial [...]
Sun BioPharma, Inc. Announces Leadership Changes
31/10/2018
David B. Kaysen Steps Down as President, CEO and Board Member Effective October 31, 2018 Michael T. Cullen MD, MBA, Executive Chairman, Elected President and CEO by Board of Directors Effective October 31, 2018 [...]
Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference
31/10/2018
JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop, will present at the [...]
HempAmericana Readies to Launch its Own Proprietary CBD Oil
31/10/2018
NEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is excited to announce that the Company is about to take delivery of the final two pieces [...]
Anchiano Therapeutics Announces Confidential Submission of Draft Registration Statement for U.S. Initial Public Offering
31/10/2018
CAMBRIDGE, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today [...]
Momenta Pharmaceuticals Announces Date of Third Quarter 2018 Financial Results Conference Call and Webcast
31/10/2018
CAMBRIDGE, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), today announced that it will release its financial results for the third quarter ended September 30, 2018 and provide a [...]

Pages